These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

367 related articles for article (PubMed ID: 29522903)

  • 21. General Challenges and Recommendations for the Water Quality Criteria of Endocrine Disrupting Chemicals (EDCs).
    Liu D; Hong Y; Feng C; Yan Z; Bai Y; Xu Y
    Bull Environ Contam Toxicol; 2022 Jun; 108(6):995-1000. PubMed ID: 35322278
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Chem Biol Interact; 2020 Aug; 326():109099. PubMed ID: 32370863
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Endocrine disruptors in the marine environment: mechanisms of toxicity and their influence on reproductive processes in fish.
    Goksøyr A
    J Toxicol Environ Health A; 2006 Jan; 69(1-2):175-84. PubMed ID: 16291569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GPER as a Receptor for Endocrine-Disrupting Chemicals (EDCs).
    Périan S; Vanacker JM
    Front Endocrinol (Lausanne); 2020; 11():545. PubMed ID: 32973678
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glucocorticoid and mineralocorticoid receptors and corticosteroid homeostasis are potential targets for endocrine-disrupting chemicals.
    Zhang J; Yang Y; Liu W; Schlenk D; Liu J
    Environ Int; 2019 Dec; 133(Pt A):105133. PubMed ID: 31520960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review on crosstalk and common mechanisms of endocrine disruptors: Scaffolding to improve PBPK/PD model of EDC mixture.
    Sharma RP; Schuhmacher M; Kumar V
    Environ Int; 2017 Feb; 99():1-14. PubMed ID: 27697394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Hengstler J; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    J Toxicol Environ Health A; 2020 Jul; 83(13-14):485-494. PubMed ID: 32552445
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuroendocrine and behavioral effects of embryonic exposure to endocrine disrupting chemicals in birds.
    Ottinger MA; Lavoie E; Thompson N; Barton A; Whitehouse K; Barton M; Abdelnabi M; Quinn M; Panzica G; Viglietti-Panzica C
    Brain Res Rev; 2008 Mar; 57(2):376-85. PubMed ID: 18006066
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanistic in silico modeling of bisphenols to predict estrogen and glucocorticoid disrupting potentials.
    Chen Q; Zhou C; Shi W; Wang X; Xia P; Song M; Liu J; Zhu H; Zhang X; Wei S; Yu H
    Sci Total Environ; 2020 Aug; 728():138854. PubMed ID: 32570315
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cloning and functional analysis of the ecdysteroid receptor complex in the opossum shrimp Neomysis integer (Leach, 1814).
    De Wilde R; Swevers L; Soin T; Christiaens O; Rougé P; Cooreman K; Janssen CR; Smagghe G
    Aquat Toxicol; 2013 Apr; 130-131():31-40. PubMed ID: 23337090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human exposure to synthetic endocrine disrupting chemicals (S-EDCs) is generally negligible as compared to natural compounds with higher or comparable endocrine activity. How to evaluate the risk of the S-EDCs?
    Autrup H; Barile FA; Berry SC; Blaauboer BJ; Boobis A; Bolt H; Hengstler J; Borgert CJ; Dekant W; Dietrich D; Domingo JL; Gori GB; Greim H; Kacew S; Marquardt H; Pelkonen O; Savolainen K; Heslop-Harrison P; Vermeulen NP
    Food Chem Toxicol; 2020 Aug; 142():111349. PubMed ID: 32360905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural and functional evidences for the interactions between nuclear hormone receptors and endocrine disruptors at low doses.
    Balaguer P; Delfosse V; Grimaldi M; Bourguet W
    C R Biol; 2017; 340(9-10):414-420. PubMed ID: 29126514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.
    McRobb FM; Kufareva I; Abagyan R
    Toxicol Sci; 2014 Sep; 141(1):188-97. PubMed ID: 24928891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Methodological issues in human studies of endocrine disrupting chemicals.
    Lee DH; Jacobs DR
    Rev Endocr Metab Disord; 2015 Dec; 16(4):289-97. PubMed ID: 26880303
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neuropeptides and enzymes are targets for the action of endocrine disrupting chemicals in the vertebrate brain.
    Panzica GC; Bo E; Martini MA; Miceli D; Mura E; Viglietti-Panzica C; Gotti S
    J Toxicol Environ Health B Crit Rev; 2011; 14(5-7):449-72. PubMed ID: 21790321
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxicological characteristics of endocrine-disrupting chemicals: developmental toxicity, carcinogenicity, and mutagenicity.
    Choi SM; Yoo SD; Lee BM
    J Toxicol Environ Health B Crit Rev; 2004; 7(1):1-24. PubMed ID: 14681080
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impacts of endocrine-disrupting chemicals on prostate function and cancer.
    Lacouture A; Lafront C; Peillex C; Pelletier M; Audet-Walsh É
    Environ Res; 2022 Mar; 204(Pt B):112085. PubMed ID: 34562481
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine and behavioral implications of endocrine disrupting chemicals in quail.
    Ottinger MA; Abdelnabi MA; Henry P; McGary S; Thompson N; Wu JM
    Horm Behav; 2001 Sep; 40(2):234-47. PubMed ID: 11534988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocrine disrupting chemicals (EDCs) and female cancer: Informing the patients.
    Rachoń D
    Rev Endocr Metab Disord; 2015 Dec; 16(4):359-64. PubMed ID: 26831296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Endocrine disruptors targeting ERbeta function.
    Swedenborg E; Pongratz I; Gustafsson JA
    Int J Androl; 2010 Apr; 33(2):288-97. PubMed ID: 20050941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.